Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Anaesthesia product has potential in developing world:

This article was originally published in Clinica

Executive Summary

An anaesthesia system developed by a UK researcher that is claimed could revolutionise surgery in the developing world has been granted a UK NESTA funding award. Dr Paul Fenton, who has devised a low-cost system combining existing and new technology, has been awarded £33,000 ($47,000) to develop the device for use in remote locations where power supplies may be erratic. The device comprises an oxygen concentrator (not the conventional pipeline or cylinder gas supply), a "Fentolater" valve and modified mechanical ventolater. The NESTA (UK National Endowment for Science Technology and the Arts) award enables Dr Fenton to develop a prototype of the device over the next year.

You may also be interested in...

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

As China Rushes Medical Supplies To World, Quality Issues Resurface

As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.

UK Regulator Puts Energies Into COVID-19 While Other Services May Take Longer

With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts